249 related articles for article (PubMed ID: 1883256)
1. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
3. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
DeVeaugh-Geiss J; Moroz G; Biederman J; Cantwell D; Fontaine R; Greist JH; Reichler R; Katz R; Landau P
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
[TBL] [Abstract][Full Text] [Related]
4. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
6. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF
Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
Gordon CT; State RC; Nelson JE; Hamburger SD; Rapoport JL
Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878
[TBL] [Abstract][Full Text] [Related]
8. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
[TBL] [Abstract][Full Text] [Related]
9. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
[TBL] [Abstract][Full Text] [Related]
10. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
[TBL] [Abstract][Full Text] [Related]
11. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Mundo E; Maina G; Uslenghi C
Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
[TBL] [Abstract][Full Text] [Related]
17. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
[TBL] [Abstract][Full Text] [Related]
18. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
Pato MT; Hill JL; Murphy DL
Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
[TBL] [Abstract][Full Text] [Related]
19. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
[TBL] [Abstract][Full Text] [Related]
20. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
